Rajah Vignesh
- SEC CIK
- 0001815042
No open-market purchases or sales filed in the past year.
Current role at each company
- YMAB Y-mAbs Therapeutics, Inc.SVP & CHIEF MEDICAL OFFICERas of Mar 7, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rajah Vignesh as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 (view filing) | Mar 5 | 2 days | Rajah VigneshSVP & CHIEF MEDICAL OFFICER | SSale | −1.71K | $16.53 | −$28.3K | −4.8%33.9K after | |
| Nov 16, 2022 (view filing) | Nov 15 | 1 day | Rajah VigneshSVP & CMO | PPurchase | +1.20K | $4.92 | +$5.88K | +38.9%4.27K after | |
| Aug 13, 2021 (view filing) | Aug 12 | 1 day | Rajah VigneshSVP & CMO | PPurchase | +1.37K | $29.95 | +$41.2K | +81.0%3.07K after |